dashboard
stocks
watchlist
Open sidebar
Sign in
Sign up
Stocks
/
ELI LILLY & Co (LLY)
ELI LILLY & Co (LLY) Stock Analysis
Healthcare
·
Pharmaceutical Preparations
$1.18K
↑
$8.31
(0.71%)
Metrics
Fair Value
Intrinsic Value
Metrics
Income Statements
Balance Sheets
Cash Flow
Quarter Comparator
Company Info
Dashboard
Stocks
Watchlist
More
Based on
TTM
(ending Q1 2026)
Basic Overview
Market Cap
$1.11T
Revenue (
TTM
)
$72.25B
Net Income (
TTM
)
$25.28B
5yr Avg. Net Income
$13.60B
Profitability
Gross Margin (
TTM
)
100.00%
5yr Avg. Gross Margin
100.00%
Profit Margin (
TTM
)
34.99%
5yr Avg. Profit Margin
25.48%
Valuation Multiples
P/E
Ratio (
TTM
)
41.67
P/S
Ratio
15.35x
PEG
Ratio
1.00x
Price/FCF (
TTM
)
93.79%
Enterprise Value
Enterprise Value (
EV
)
$1.15T
EV/Earnings
45.45x
EV/FCF
97.17x
Cash Flow
Free Cash Flow (
FCF
)
$11.82B
5yr Avg.
FCF
$6.12B
Owner Earnings (
TTM
)
$18.44B
5yr Avg. Owner Earnings
$9.72B
Returns on Capital
Return on Assets (
ROA
)
22.07%
Return on Equity (
ROE
)
81.02%
ROIC
(Standard)
0.00%
5-Year Average
0.00%
ROIC
(Core)
0.00%
ROIC
(Operating)
0.00%
Book Value & Dividends
Book Value (
TTM
)
$31.20B
5yr Book Value Growth
192.94%
10yr Book Value Growth
169.13%
Dividend Yield (
TTM
)
1.02%
Dividends Paid
$5.59B
